Inventage Lab

Inventage Lab Accounts Payable

The Accounts Payable of Inventage Lab (389470.KQ) as of Oct 19, 2026 is 2.47 B KRW.

Accounts Payable

2.47 BKRW

Last updated:

Accounts Payable of Inventage Lab is 2025 2.47 B KRW. Accounts Payable of Inventage Lab was 2024 - KRW. It decreases by % lower compared to the previous year.

The Inventage Lab Accounts Payable history

The Inventage Lab Accounts Payable history
YEARAccounts PayableYoY
2.47 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inventage Lab Stock analysis

What does Inventage Lab do? Inventage Lab Inc, based in Seongnam, South Korea, operates in the Health Care sector within Biotechnology. The company develops and commercializes human medicines for conditions including male pattern baldness, dementia, and prostate cancer, alongside veterinary medicines such as combination drugs and chemical castration agents. Founded with a focus on long-acting injection platforms and genetic material delivery systems, Inventage Lab employs 66 staff and went public on 22 November 2022. Inventage Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inventage Lab stock

Accounts Payable of Inventage Lab is 2.47 B KRW in 2025.

On Eulerpool you can find the complete historical development of Accounts Payable Inventage Lab since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Inventage Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Inventage Lab

All Key Metrics — Inventage Lab